Health Populi
MARCH 11, 2021
health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act. In the case of Medicare Part D, the drug benefit, Chandra said, “If you’re sick enough to fall into the donut hole, you may have higher mortality.”
Healthcare IT Today
SEPTEMBER 24, 2023
This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Collaborations between AI vendors and biotech/pharma companies over the last five years are worth more than $45 billion , according to a recent report from Accenture.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT Today
MAY 7, 2023
This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. The silver lining: Healthcare is the leading sector, though most funds are going to biotech. Welcome to the weekly edition of Healthcare IT Today Bonus Features.
Digital Health Today
OCTOBER 16, 2019
Like Eko, S-There Technologies and TripleW have devices that allow remote monitoring of patients, presumably capitalizing on the new reimbursement opportunities for Remote Patient Monitoring in the last two Medicare Physician Fee Schedules. Can't meet you there? No problem! Carrie Nixon. Carrie Nixon, Esq.
Healthcare IT Today
OCTOBER 11, 2023
This article will be a roundup of interesting stories, product announcements, partnerships, research studies, company launches, and more from the annual conference. Optum and Uber are partnering to make non-urgent medical transportation and healthy food delivery covered benefits for certain Medicare Advantage plans beginning in 2024.
Insulin Nation
DECEMBER 18, 2013
A state-of-the-art wound therapy that prevents amputations is under threat from proposed cuts in Medicare reimbursement rates, according to regenerative medicine experts. In a recent Fierce Biotech article, CEO MacKay warned his staff of “heartbreaking” staff cuts to make the new pricing structure work.
Health Populi
JANUARY 18, 2019
He co-wrote the first “It’s The Prices Stupid” research article in Health Affairs with Gerard Anderson et. First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective.
Expert insights. Personalized for you.
245 
Let's personalize your content